Zobrazeno 1 - 10
of 70
pro vyhledávání: '"C. Pellizzaro"'
Autor:
M. AVEIRO, Q. C. PELLIZZARO, R. D. M. C. AMBONI, C. R. V. BATISTA, L. H. BEIRÃ?O, P. L. M. BARRETO
Publikováno v:
Alimentos e Nutrição, Vol 18, Iss 2, Pp 121-126 (2008)
This study was carried out to evaluate the physical-chemical, microbiological and sensory attributes of the brown mussel (Perna perna) marinated with two different sauces. Microbiological, chemical and sensory changes were monitored, at 4ºC (±1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::ed43eedc1e6e09de38fc0a9367655163
http://serv-bib.fcfar.unesp.br/seer/index.php/alimentos/article/view/144
http://serv-bib.fcfar.unesp.br/seer/index.php/alimentos/article/view/144
Autor:
Gianni Sava, Sonia Zorzet, C. Pellizzaro, Gabriella Abolafio, Silvia Cantoni, Danila Coradini, C. Garrovo, Alberto Perbellini, Maria Grazia Daidone, Ignazio Scarlata, Maya Fedeli, Annalisa Speranza
Publikováno v:
Leukemia. 20:785-792
All-trans retinoic acid (ATRA) represents the therapy of choice for patients with acute promyelocytic leukemia (APL). However, patients often relapse due to ATRA-resistance. The molecular basis of APL alterations indicates that addition of a histone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f59424eeccb2b197ebca4ce791b6831
https://doi.org/10.1038/sj.leu.2404179
https://doi.org/10.1038/sj.leu.2404179
Publikováno v:
Anti-Cancer Drugs. 16:373-379
In this review we focus on a promising novel histone deacetylase (HDAC) inhibitor (HA-But) obtained by the esterification of butyric acid (BA), the smallest HDAC inhibitor, with hyaluronic acid (HA), the main constituent of the extracellular matrix w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad4d960b0e3a01b871adb9a641604240
https://doi.org/10.1097/00001813-200504000-00003
https://doi.org/10.1097/00001813-200504000-00003
Publikováno v:
Cellular and Molecular Life Sciences (CMLS). 61:76-82
Angiogenesis activation mediated by vascular endothelial growth factor (VEGF) is one of the factors that can cause antiestrogen treatment failure in estrogen receptor (ER)?positive breast cancer patients. Since VEGF synthesis is modulated not only by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07e9dd780194a2366b812d4dd6d3fce8
https://doi.org/10.1007/s00018-003-3324-0
https://doi.org/10.1007/s00018-003-3324-0
Publikováno v:
British Journal of Cancer
To obtain a more integrated understanding of the different breast cancer phenotypes and to investigate whether bio-molecular profiles can distinguish between specific histotypes, we explored the interrelations among several biologic variables indicat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6094d1a468a59193a90852ac3a4e098
https://doi.org/10.1038/sj.bjc.6600556
https://doi.org/10.1038/sj.bjc.6600556
Publikováno v:
Cell Proliferation. 33:139-146
Sodium butyrate (NaB), a product of colonic fermentation of dietary fibre, has been shown to inhibit cell proliferation by blocking cells in the G0/G1 phase of the cell cycle through a mechanism of action still not completely understood. We investiga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4489820c4558ebe943aaef42d66dfdeb
https://doi.org/10.1046/j.1365-2184.2000.00173.x
https://doi.org/10.1046/j.1365-2184.2000.00173.x
Autor:
Giuliana Miglierini, Alberto Perbellini, Danila Coradini, C. Pellizzaro, Maria Grazia Daidone
Publikováno v:
Scopus-Elsevier
The potential clinical utility of sodium butyrate, a natural compound known to inhibit tumor-cell growth, is hampered by the difficulty of achieving effective in-vivo concentrations. The short half-life (about 5 minutes) of sodium butyrate results in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3c1b88aad1febb26972a96996a59071
https://doi.org/10.1002/(sici)1097-0215(19990505)81:3<411::aid-ijc15>3.0.co
https://doi.org/10.1002/(sici)1097-0215(19990505)81:3<411::aid-ijc15>3.0.co
Publikováno v:
Cell Proliferation. 30:149-159
We have investigated the effects exerted by sodium butyrate (NaBu) on the growth and cell cycle perturbations of four human breast cancer cell lines (MCF7, T47D, MDA-MB231 and BT20) with different steroid receptor profiles. Moreover, since one of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f01cc9e0770b3fbd6c57d82e5bd1ffe8
https://doi.org/10.1111/j.1365-2184.1997.tb00931.x
https://doi.org/10.1111/j.1365-2184.1997.tb00931.x
Publikováno v:
Tumor Biology. 18:22-29
To improve the effectiveness of 4-hydroxyphenylretinamide (4-HPR), an analogue of retinoic acid used in chemoprevention and treatment of breast cancer, we investigated the effect of concomitant administration of 4-HPR (0.1, 1 microM) and tamoxifen (T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4782cfc1c8a43f6328fc9ca54cc4da70
https://doi.org/10.1159/000218012
https://doi.org/10.1159/000218012
Autor:
Roberto Doci, C. Pellizzaro, Danila Coradini, Aurora Costa, Leandro Gennari, Mariagrazia Di Rocco
Publikováno v:
Journal of Hepatology. 40:563-565
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::370d42044f2dcbd98931541632e62daf
https://doi.org/10.1016/j.jhep.2003.10.031
https://doi.org/10.1016/j.jhep.2003.10.031